Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2016 Mar;38(2):131–138. doi: 10.1097/MPH.0000000000000506

Table I. Characteristics of the Patient and Control Populations.

Patients (n=126) Controls (n=114) P value
Age 0.0001
<18 months 58 0
>18 months 68 114

Gender 0.52
Female 61 (48%) 50 (44%)
Male 65 (52%) 64 (56%)

Ethnicity 0.3
Hispanic 30 (24%) 31 (27%)
NH White 71 (56%) 57 (50%)
NH Black 12 (10%) 16 (14%)
Other 12 (10%) 10 (9%)

INSS Tumor Stage
Stage 1 10 (8%)
Stage 2 17 (13%)
Stage 3 30 (24%)
Stage 4 59 (47%)
Stage 4S 8 (6%)
Unknown 2 (2%)

Risk Group
Low 22 (18%)
Intermediate 30 (24%)
High 61 (48%)
Unknown 13 (10%)

MYCN status
Amplified 35 (28%)
Non-amplified 67 (53%)
Unknown 24 (19%)